Understanding Pseudohypoaldosteronism in Young Children
Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation: Diagnosis and Management in a French Retrospective Study
This study looks at how common pseudohypoaldosteronism is in young children under six months old with urinary tract issues to find better ways to treat them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 1 Year to 6 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06905600 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on pseudohypoaldosteronism, a rare condition affecting children under six months old, particularly in the context of urinary tract malformations. The study aims to gather data on the prevalence and management of this condition across France, as current knowledge and treatment protocols are limited. By raising awareness among healthcare professionals and analyzing patient data, the study seeks to identify optimal treatment strategies for affected children.
Who should consider this trial
Good fit: Ideal candidates for this study are children under six years old diagnosed with pseudohypoaldosteronism related to urinary malformations or infections.
Not a fit: Patients who do not have pseudohypoaldosteronism or are older than six years will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of pseudohypoaldosteronism in young children.
How similar studies have performed: While there is limited data on similar studies, the focus on a rare condition like pseudohypoaldosteronism represents a novel approach in pediatric research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Minor subjects aged less than 6 years at the time of diagnosis * Diagnosis of pseudohypoaldosteronism in the context of urinary malformation and/or urinary infection between January 1, 2018 and December 31, 2023 * Subject (and/or their parental authority) having not expressed, after information, their opposition to the reuse of their data for the purposes of this research. Exclusion Criteria: * Subject (or their parents) having expressed their (their) opposition to participating in the study
Where this trial is running
Strasbourg
- Service pédiatrie 1 - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Ariane ZALOSZYC, MD
- Email: ariane.zaloszyc@chru-strasbourg.fr
- Phone: 33 3 88 12 77 42
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.